NYSE: XYLXylem Inc.

    Xylem authorises new $1.5 billion share repurchase program

    • US stocks
    • Mergers & acquisitions
    • Industrials

    Xylem (NYSE: XYL) said on 13 Nov 2026 that its board of directors approved a new share repurchase program authorising the company to buy up to $1.5 billion of its common stock. The program has no expiration date, and the company says it is not obliged to acquire any particular amount of stock under it.

    Key highlights

    • New share repurchase authorisation: $1.50 billion
    • Par value of common stock covered: $0.01 per share
    • Expiration date: none stated in the program

    The program in numbers

    ItemDetail
    CompanyXylem Inc. (NYSE: XYL)
    Board approval date13 Nov 2026
    Maximum authorisation$1.50 billion
    Security coveredCommon stock, $0.01 par value per share
    ExpirationNone; the program has no expiration date
    SuspensionThe company may suspend the program at any time at its discretion

    Repurchases may be made in several ways

    Timing and amounts are left to the company, which says it may buy at such times and in such amounts, not exceeding the $1.50 billion aggregate authorisation, as it deems advisable.

    No minimum purchase commitment

    The company states that the new program does not obligate it to acquire any particular amount of common stock. It may also suspend the program at any time at its discretion.

    The filing describes the authorisation as a maximum, not a schedule of purchases.

    What the Xylem buyback program means for XYL shareholders

    The authorisation sets a ceiling of $1.50 billion on repurchases of common stock, with no end date and no minimum amount the company must buy. What the company actually repurchases, and when, is not stated in the filing.

    The filing does not say how much of any earlier program remains or is replaced, what funds will be used, or what effect the program is expected to have on earnings or the share count. The next dated step is not set in the filing.

    Filed with the US SEC on . Reference: Original filing (SEC)

    Disclaimer:

    The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.

    Figures are from the company's filings with the US Securities and Exchange Commission and are in US dollars. Investing in US stocks from India is subject to the Liberalised Remittance Scheme, currency risk and taxes in both countries.

    Latest posts